- Home
- RSLS vs TTNP Comparison
RSLS vs TTNP Comparison
Compare RSLS & TTNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RSLS
- TTNP
- Stock Information
- Founded
- RSLS 2002
- TTNP 1991
- Country
- RSLS United States
- TTNP United States
- Employees
- RSLS N/A
- TTNP N/A
- Industry
- RSLS Medical/Dental Instruments
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RSLS Health Care
- TTNP Health Care
- Exchange
- RSLS Nasdaq
- TTNP Nasdaq
- Market Cap
- RSLS 3.2M
- TTNP 3.4M
- IPO Year
- RSLS 2007
- TTNP 1996
- Fundamental
- Price
- RSLS $0.64
- TTNP $3.59
- Analyst Decision
- RSLS Hold
- TTNP
- Analyst Count
- RSLS 1
- TTNP 0
- Target Price
- RSLS N/A
- TTNP N/A
- AVG Volume (30 Days)
- RSLS 3.3M
- TTNP 58.6K
- Earning Date
- RSLS 03-31-2025
- TTNP 03-31-2025
- Dividend Yield
- RSLS N/A
- TTNP N/A
- EPS Growth
- RSLS N/A
- TTNP N/A
- EPS
- RSLS N/A
- TTNP N/A
- Revenue
- RSLS $8,183,000.00
- TTNP N/A
- Revenue This Year
- RSLS $17.47
- TTNP N/A
- Revenue Next Year
- RSLS $20.00
- TTNP N/A
- P/E Ratio
- RSLS N/A
- TTNP N/A
- Revenue Growth
- RSLS N/A
- TTNP N/A
- 52 Week Low
- RSLS $0.63
- TTNP $3.03
- 52 Week High
- RSLS $29.00
- TTNP $14.80
- Technical
- Relative Strength Index (RSI)
- RSLS 19.59
- TTNP 48.42
- Support Level
- RSLS $0.63
- TTNP $3.20
- Resistance Level
- RSLS $1.28
- TTNP $4.39
- Average True Range (ATR)
- RSLS 0.15
- TTNP 0.47
- MACD
- RSLS 0.05
- TTNP -0.05
- Stochastic Oscillator
- RSLS 1.15
- TTNP 30.23
About RSLS ReShape Lifesciences Inc.
Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus.
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.